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ABSTRACT The spectroscopic and reactivity properties of hemin complexes formed with cyanogen bromide fragments B
(residues 1–123), C (124–298), A (299–585), and D (1–298) of human serum albumin (HSA) have been investigated. The
complex hemin-D exhibits binding, spectral, circular dichroism, and reactivity characteristics very similar to those of
hemin-HSA, indicating that fragment D contains the entire HSA domain involved in heme binding. The characteristics of the
other hemin complexes are different, and a detailed investigation of the properties of hemin-C has been carried out because
this fragment contains the HSA binding region of several important drugs. Hemin-C contains a low-spin Fe(III) center, with two
imidazole ligands, but the complex undergoes a reversible structural transition at basic pH leading to a high-spin, five-
coordinated Fe(III) species. This change determines a marked increase in the relaxation rate of water protons. Limited
proteolysis experiments and mass spectral analysis carried out on fragment C and hemin-C show that the region encom-
passing residues Glu-208 to Trp-214 is protected from activity of proteases in the complex and, therefore, is involved in the
interaction with hemin. A structural model of fragment C enables us to propose that His-242 and His-288 are the axial ligands
for the Fe(III) center.
INTRODUCTION
Heme is one of the most versatile prosthetic groups present
in metalloproteins, which play important roles in electron
transfer reactions, oxygen transport and storage, and a va-
riety of oxidation processes that use dioxygen, hydrogen
peroxide, or alkyl peroxides as terminal oxidants (Kadish et
al., 1999; Xie and Dolphin, 1994; Dawson, 1988). In addi-
tion, heme serves regulatory functions in many biological
processes such as protein synthesis (Ochoa and de Haro,
1979), cellular growth and differentiation (Sassa, 1988), and
the activation of soluble guanylate cyclase by nitric oxide
(Ignarro et al., 1982). Heme is released in plasma upon
rupture of red blood cells in many events, including hemo-
lysis, trauma and ischemia reperfusion (Jacob, 1994). In
these conditions, it is currently thought that human serum
albumin (HSA) and hemopexin serve as traps for extracel-
lular heme, to prevent its toxic effects and convey it to its
specific catabolism site (Balla et al., 1993). However, Miller
and Shaklai (1999) have recently reported that HSA and
hemopexin are not capable of preventing oxidative damage
of low-density lipoprotein by the transient hemin. He-
mopexin is the strongest heme-binding protein in plasma
(Kb 10
9 M1 (Hrkal et al., 1974)), and in normal conditions
albumin rapidly transfers the heme to hemopexin. However,
the abundance of hemopexin in plasma is low (10–20 M),
and albumin can thus play an important role as heme carrier
in conditions where hemopexin is saturated (Peters, 1996).
Some recent results from reactivity studies may extend the
currently accepted role and significance of heme binding by
HSA. In fact, we have found that the hemin-HSA complex
exhibits catalase and peroxidase activity (Monzani et al.,
2001). Although this activity is weak, considering the large
abundance of HSA, it may contribute to the antioxidant
defense in the extracellular fluids of the human body, where
the presence of antioxidant enzymes is scarce.
Although a detailed structural description of the heme
binding site in HSA is lacking, insight into its position has
been obtained by circular dichroism (CD) studies of the
complexes between ferric heme and the three recombinant
HSA domains I (residues 1–197), II (residues 189–385),
and III (residues 381–585) (Dockal et al., 1999). Based on
these studies, it was concluded that the main contribution to
the HSA primary binding site for hemin is due to domain I.
Other studies aimed at addressing the location of the heme
binding site were performed using the large cyanogen bro-
mide fragments of HSA (Hrkal et al., 1978), and in this
case, it was proposed that the heme binding site is mainly
included in the HSA middle region corresponding to frag-
ment C (residues 124–298) (Hrkal et al., 1978). Spectro-
scopic studies on various derivatives of the hemin-HSA
complex (Casella et al., 1993; Monzani et al., 2001; Fasano
et al., 2001) and docking simulations (Fasano et al., 2001)
based on the crystal structure of HSA (He and Carter, 1992)
suggest that the heme iron center is axially bound to a
histidine and possibly to a tyrosine residue. This type of
detailed analysis is currently unavailable for the hemin
complexes formed by the HSA fragments. In the present
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paper we report the binding and spectral properties as well
as the reactivity of the hemin complexes of the cyanogen
bromide fragments of HSA, which, according to Lapresle
(Doyen et al., 1982), here will be designated as B (residues
1–123), C (residues 124–298), and A (residues 299–585).
An additional fragment, D (residues 1–298), made of B and
C, which is a result of the incomplete cleavage of the
peptide bond between Met-123 and Cys-124 was also used
(Doyen et al., 1982). For the adduct of fragment C with
hemin (hemin-C) and its analog with Mn(III)-protoporphy-
rin IX (Mn(III)-PPIX-C), containing Mn(III) in the place of
Fe(III), the relaxometric properties were investigated.
Moreover, the interaction between hemin and fragment C
has been studied by limited proteolysis and mass spectrom-
etry. The combination of the various approaches allowed us
to obtain a structural description of the heme environment in
this albumin fragment and showed that, although it is not
fully representative of the heme binding site, it contains a
portion of the HSA high-affinity site for the ligand.
MATERIALS AND METHODS
Materials
HSA was purified from fresh serum by anion-exchange chromatography on
a DEAE Sephadex, column and the purity of the protein was checked by
SDS-PAGE (Galliano et al., 1990). The HSA fragments were prepared
according to Lapresle and Doyen (1975) with slight modifications. The
unreduced protein was treated with cyanogen bromide in 70% formic acid,
and the four fragments were fractionated by gel filtration on a Superdex 75
column (80  1.6 cm) equilibrated with 5% propionic acid and 0.15 M
NaCl followed by ion-exchange chromatography on carboxymethyl (CM)
cellulose (2.5 10 cm) equilibrated with 0.01 M phosphate buffer, pH 2.7,
and eluted with a linear gradient from 0.05 to 0.3 M NaCl. The molar
extinction coefficients of the fragments were calculated on the basis of
their amino acid sequence with the Compute tool of ExPASy (http://
www.expasy.ch) at the University of Geneva, Switzerland. Hemin chlo-
ride, trypsin treated with L-tosylamido-2-phenylethyl chloromethyl ketone,
chymotrypsin, subtilisin, and protease V8 were purchased from Sigma
Chemical Co. (St. Louis, MO). All other chemicals (from Sigma) were
reagent grade and used as received. Aqueous buffers were prepared from
double-distilled water. Hydrogen peroxide solutions for kinetic experi-
ments were prepared by dilution of a 30% aqueous solution and were
standardized by iodimetry. UV-Vis and CD spectra were measured with
HP8452A (Hewlett-Packard, Waldbronn, Germany) and CADAS (Dr.
Lange, Berlin, Germany) spectrophotometers and a J710 (Jasco Europe,
Cremella, Italy) dichrograph, respectively. The RP-HPLC C18 column
(250  2.1 mm) was purchased from Phenomenex (Palo Alto, CA).
Binding experiments
Binding experiments of hemin or Mn(III)-PPIX to the HSA fragments were
studied spectrophotometrically using an optical cell with 10-cm path
length. A small amount of a solution of hemin in dimethylsulfoxide
(DMSO; 3103 M) was diluted in the optical cell in a solvent mixture
of DMSO-aqueous 0.1 M phosphate buffer, pH 7.0, 1:10 (v/v), or 2:10
(v/v) in the case of fragment D (final protein concentration5 107 M).
This solution was titrated with the HSA fragment by adding small amounts
of an 0.3 mM protein solution in the aqueous buffer and recording the
spectrum after incubation for a few minutes after each addition. Difference
spectra with respect to hemin were taken, and the binding isotherm was
analyzed by plotting the difference of absorbance between the maximum
and the minimum of the two-signed difference spectra against the protein
concentration. The equation derived for a high-affinity equilibrium was
applied to fit the binding data (Monzani et al., 2001).
Kinetics
The kinetic experiments on the catalytic oxidation of phenolic substrates by
hydrogen peroxide in the presence of hemin-HSA fragments were carried
out in a magnetically stirred and thermostated optical cell of 1-cm path
length, at 25.0  0.1°C, in 0.1 M phosphate buffer, pH 7.0, following
procedures described previously for the reactions catalyzed by the hemin-
HSA complex (Monzani et al., 2001). The phenolic substrates studied were
p-cresol, p-hydroxyphenyl propionic acid, tyramine, and L- and D-tyrosine.
For each substrate, the reaction rates were studied as a function of both
hydrogen peroxide and substrate concentrations. The reactions were fol-
lowed spectrophotometrically at 300 nm, where the dimeric products of
phenol coupling absorb (Casella et al., 1994). The initial rates were
determined from the linear part of the plots of absorbance versus time.
The  values necessary to convert the rate data from absorbance/s to
M/s were reported previously (Monzani et al., 2001).
NMR relaxation
Water proton T1 measurements were obtained on a Stelar SpinMaster
Spectrometer (Stelar, Mede, Italy) operating at 20 MHz, by means of the
inversion-recovery technique (16 experiments; 4 scans) (Braun et al.,
1998). Magnetization values were obtained by averaging the first 128 data
points of the free induction decay. A typical 90° pulse width was 3.5 s.
The reproducibility in T1 measurements was 0.5%. The temperature was
controlled by a Stelar VTC-91 airflow heater, equipped with a copper-
constantan thermocouple; the actual temperature in the probe head was
measured with a Fluke 52 k/j digital thermometer (Fluke, Zu¨rich, Switzer-
land), with an uncertainty of 0.3°C.
Values of r1p were determined by subtracting from the observed relax-
ation rate (R1
obs) the blank relaxation rate value (R1
dia) measured for solu-
tions containing the HSA fragment in the same concentration without the
paramagnetic prosthetic group.
Variable temperature 17O-NMR linewidth measurements were recorded
at 9.4 T on a JEOL EX-400 spectrometer (JEOL, Tokyo, Japan), equipped
with a 5-mm inner diameter probe head, with a D2O external lock. Sample
solutions were supplemented with enriched H2
17O (Cortec, Paris, France)
to an isotopic abundance of 2.6%. Experimental settings were 22-kHz
spectral width, 90° pulse for 14 s, 0.75-s acquisition time, 256 scans, and
no sample spinning.
Limited proteolysis experiments
Limited proteolysis experiments were carried out by incubating fragment C
or the hemin-C complex with trypsin, chymotrypsin, subtilisin, and pro-
tease V8 as enzymatic probes. Digestions were all performed in 100 mM
sodium phosphate (pH 7.0) containing 8% DMSO, at 30°C and using
various enzyme to substrate (E/S) ratios (w/w). The extent of the reaction
was monitored on a time course basis by sampling the incubation mixture
at different time intervals. Digested protein samples were acidified by
adding trifluoroacetic acid (TFA) to lower the pH. Peptide mixtures from
the different proteolysis experiments were fractionated by reverse-phase
HPLC on a Phenomenex C18 column. Peptides were eluted by means of a
linear gradient from 5% to 60% of acetonitrile in 0.1% aqueous TFA
over 60 min, and elution was monitored at 220 and 280 nm. Fractions
were manually collected and identified by electrospray mass spectrom-
etry ES/MS.
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The complex hemin-C was formed by incubation of fragment C in 100
mM sodium phosphate, pH 7.0, and a 10-fold molar excess of a hemin
solution in DMSO to obtain 8% DMSO as a final concentration; the
complex was then allowed to form for 10 min at 30°C before the protease
addition.
Mass spectrometry
Protein samples and proteolytic fragments were analyzed by ES/MS using
an API 100 single-quadrupole mass spectrometer (Applied Biosystems,
Firmingham, MT) equipped with an ion spray source. Samples were
injected into the atmospheric pressure ion source via a syringe pump at a
flow rate of 5 l/min. Data were acquired and elaborated with the software
provided by the manufacturer. Mass calibration was performed by means
of multiply charged ions from a separate injection of horse heart myoglobin
(Sigma; average molecular mass, 16,951.5 Da); all masses are reported as
average values.
ES/MS analysis of fragment C and hemin-C
Fragment C was eluted from a Phenomenex C4 column by means of a
linear gradient from 20% to 65% of acetonitrile in 0.1% aqueous TFA over
30 min; elution was monitored at 220 and 280 nm. The molecular weight
of the HPLC-purified peptide was determined by ES/MS analysis.
The hemin-C complex was formed in 100 mM phosphate buffer, 1%
cetyltrimethylammonium bromide (cTAB), pH 7, and then subjected to gel
filtration chromatography on a PD10 prepacked column (Sephadex G25,
Pharmacia, Uppsala, Sweden), eluted with 50 mM ammonium acetate, pH
7.0. The complex (10 pmol/l) was directly injected into the ion source of
the API 100 mass spectrometer. Instrumental parameters for the mass
analysis were appropriately set to avoid complex dissociation in the gas-
eous phase.
Structural analysis
Structural analysis, including electrostatic potential surface calculations,
was performed by means of the Swiss-PdbViewer version 3.7 b2 (Guex
and Peitsch, 1997).
RESULTS
Spectra and binding characteristics
The electronic spectrum of hemin in a dilute solution of
10% DMSO-aqueous phosphate buffer at pH 7.0 exhibits
the typical features of high-spin ferric heme (Owens and
O’Connor, 1988): Soret band at 400 nm,  band at 498 nm,
 band almost absent, and charge transfer (CT) band at 620
nm. In the spectrum of the hemin-HSA adduct recorded in
the same conditions, the Soret band broadens and shifts to
404 nm, and new contributions to the spectrum are given by
a detectable  band at 530 nm and a CT band at 580 nm
(Monzani et al., 2001). The spectral features of the hemin-D
complex are similar to those of hemin-HSA but with a
larger contribution by the low-spin component, as shown by
the more prominent  band at 532 nm (Fig. 1 A). By
contrast, the spectrum of the hemin-C complex appears to
be totally low spin: sharp Soret band at 412 nm and  and
 bands at 534 and 566 nm, respectively. The spectrum of
this complex exhibits a pronounced pH dependence, with a
reversible shift of the Soret band to 394 nm in basic solution
(pH  10).
Hemin binds to fragment A essentially as a low-spin
species, as suggested by the Soret band at 414 nm and  and
 bands at 534 and 566 nm, respectively, but the presence
of a small fraction of high-spin species is indicated by the
CT shoulder near 630 nm (Fig. 1 A). Finally, the electronic
spectrum of hemin-B resembles that of free hemin, although
even in this case a slight broadening of the Soret band at
lower energy and a detectable shoulder near 530 nm, cor-
responding to an  band indicate the existence of a small
fraction of low-spin form. Note that the spectra of hemin-A
and especially hemin-B obtained in our conditions are much
sharper in the Soret region than those reported previously by
Hrkal et al. (1978), probably because these authors studied
the complexes between hemin and HSA fragments in aque-
ous buffer (without addition of DMSO), where hemin is
aggregated. Because HSA itself is hardly able to destroy the
aggregates and bind monomeric hemin (Kuzelova et al.,
1997), it is likely that the same problem occurs with HSA
fragments.
Complementary information could be obtained by replac-
ing ferric heme with the analog Mn(III)-PPIX complex, as
already reported for hemin-HSA (Fasano et al., 2001). At
pH 7.0 (phosphate buffer 0.1 M), Mn(III)-PPIX-C exhibits
a strong absorption at 369 nm, with minor bands at 468 and
559 nm. This pattern resembles that observed for Mn(III)-
PPIX-HSA (i.e., 370, 465, and 561 nm for , , and 
bands, respectively) and supports the evidence for a six-
coordinated heme complex for Mn(III) as well. Although
the  band is almost unaffected by the pH value, the  band
appears to be more diagnostic; actually, a shift from 467 to
447 nm is observed for Mn(III)-PPIX-HSA on going from
pH 6 to 10. The same behavior is shown by the  band,
which is red-shifted from 556 to 571 nm. According to the
proposed mechanism, the spectral changes are the result of
the displacement of a water molecule by a tyrosyl oxygen as
the sixth ligand of Mn(III)-PPIX (Fasano et al., 2001). In the
case of Mn(III)-PPIX-C,  and  bands undergo only mod-
est shifts from 468 to 464 nm and from 559 to 563 nm,
respectively. These figures cannot be associated with a
change of the coordination state of the metal ion, as it occurs
with hemin-C, or ligand exchange, as it occurs with
Mn(III)-PPIX-HSA, as a function of pH. It is likely that
Mn(III) is bound to two axial histidines in Mn(III)-
PPIX-C, as is Fe(III) in hemin-C, but that neither of the
histidine ligands is released in basic medium, because of
the stronger preference of Mn(III)-porphyrins for imida-
zole ligands with respect to the Fe(III) analogs (Mashiko
and Dolphin, 1987). Spectral features similar to Mn(III)-
PPIX-C and Mn(III)-PPIX-HSA are observed for
Mn(III)-PPIX-D: , , and  bands occur at 369, 465,
and 556 nm (pH 7.0), with an appreciable shift in basic
medium, i.e., at 364, 465, and 567 nm (pH 10.5), respec-
tively. In this case it is difficult to draw any firm con-
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clusion about the manganese axial ligands, although the
spectral behavior resembles more that of Mn(III)-PPIX-C
than that of Mn(III)-PPIX-HSA.
By titrating solutions of hemin in a DMSO-aqueous
buffer at pH 7.0 with the HSA fragments it has been
possible to estimate the affinity of hemin for the various
polypeptides. The use of DMSO in these experiments is
convenient to prevent heme aggregation in aqueous solu-
tion. The plots obtained from difference spectra were in fact
well behaved, and the resulting binding constants are col-
lected in Table 1. DMSO affects the value of the binding
constants only marginally. For instance, the Kb value of
hemin for HSA that we found in DMSO-aqueous buffer
10% (v/v), (3.4  0.6)  107 M1 (Monzani et al., 2001),
is only slightly lower than that determined in pure buffer
through fluorescence measurements, 5  107 M1 (Beaven
et al., 1974). We have also found here that on increasing the
amount of DMSO in the solution from 10% to 20% (v/v) the
FIGURE 1 (A) Electronic spectra of hemin com-
plexes with HSA fragments A (— ——), B (  ), C
(—   —), and D (——) in DMSO-aqueous 0.1 M
phosphate buffer, pH 7.0, 1:10 (v/v), or 2:10 (v/v) in
the case of fragment D. Concentrations of the ad-
ducts were 5  107 M, and path length was 10
cm. (B) Circular dichroism spectra of hemin com-
plexes with HSA fragment B (gray trace), C (dotted
trace), and D (black trace) (same conditions as
above).
TABLE 1 Binding constants of hemin and Mn(III)-PPIX to
HSA fragments in DMSO-aqueous 0.1 M phosphate buffer,
pH 7.0, at 20°C
Complex Kb (M
1)
Hemin-A (2.1  0.1)  106
Hemin-B (1.3  0.1)  105
Hemin-C (9.3  0.3)  105
Hemin-D (2.6  0.3)  107
Mn(III)-PPIX-C (6.1  3.4)  106
Mn(III)-PPIX-D (3.1  1.7)  106
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Kb value of hemin for fragment C slightly decreases to
(5.5  0.3)  105 M1. The Kb value reported for hemin-D
in Table 1 is only slightly lower than that determined for
hemin-HSA (Monzani et al., 2001). For the other fragments
the affinity of hemin is significantly lower than for the intact
protein, but we note that the values of the binding constants
that we find here are significantly larger than those reported
previously by Hrkal et al. (1978), particularly for hemin-A
and hemin-B. Likely, this is because of the same problem of
heme aggregation in aqueous buffer solution discussed
above. The affinity of Mn(III)-PPIX for HSA fragments C
and D has been measured as well. Unlike hemin, this
complex shows comparable affinities for the two polypep-
tides, with a slightly larger value of the binding constant in
the case of fragment C (Table 1).
The affinity of Mn(III)-PPIX for these fragments is com-
parable with that for HSA.
Circular dichroism spectra.
The far-UV CD spectra of HSA fragments A, B, and C were
reported previously by Hrkal et al. (1978). The spectra
indicated significant portions of -helical structure, compa-
rable with that of HSA. In the CD spectrum of fragment D,
the -helical content is further slightly increased (data not
shown). We also investigated the effect of hemin binding to
the four HSA fragments in the CD spectra. It was found that
the binding occurs without any significant change in the
far-UV CD features of the peptides, but changes are observ-
able in some cases in the near-UV region, where the HSA
fragments exhibit a broad negative band near 260 nm, which
is only partially resolved from the more intense negative CD
activity at higher energy. The intensity of this aromatic CD
band increases in the order of B  C  A  D. However,
upon binding of hemin to the HSA fragments, the CD
activity of the aromatic envelope remains basically unaf-
fected for A and B, whereas it is slightly strengthened for C
and strongly enhanced in the case of D. For hemin-C and
hemin-D, additional CD activity of positive sign occurs in
the range between 300 and 350 nm. The increase of optical
activity in the aromatic region for these complexes parallels
the behavior observed for hemin binding to HSA (Monzani
et al., 2001) and can be attributed to reduced conformational
mobility of the aromatic residues of the proteins in the
binding site.
The CD spectra of the hemin complexes with the four
HSA fragments are particularly informative in the visible
region, where the induced CD activity in the porphyrin
chromophore is observed. These spectra show remarkable
differences (Fig. 1 B). Hemin-D exhibits a major negative
peak near 395 nm and a minor positive peak near 420 nm.
For hemin-C the spectrum is different and features a single
negative peak near 415 nm, practically coincident with
the Soret absorption maximum. For hemin-A the CD
activity is extremely weak, and for hemin-B the CD is
basically absent.
The CD spectrum of hemin-C undergoes reversible
changes with pH that parallel the changes observed in the
electronic spectrum. On increasing the pH from 7.0 to 10.0 a
progressive decrease in the negative CD peak at 415 nm and
an increase of the broad CD activity of positive sign be-
tween 350 and 400 nm, featuring a maximum near 385 nm,
occur. Isodichroic points are observable near 280 and 340
nm. Overall, the optical activity within the Soret band is
reduced by more than 50% in the basic pH range, and the
protein CD band near 260 nm becomes weaker and less
defined.
Kinetics
For comparative purposes, we chose to investigate the
peroxidase-like activity of the present hemin complexes
with the same group of phenolic substrates previously
studied with hemin-HSA (Monzani et al., 2001), namely,
p-cresol (1), p-hydroxyphenyl propionic acid (2), tyra-
mine (3), and L- and D-tyrosine (L-4 and D-4). Given the
similarity in general behavior with hemin-HSA, the same
catalytic mechanism can be assumed for the hemin com-
plexes with HSA fragments. This is reproduced in
Scheme 1, where E is the hemin-peptide complex, EA the
active species, S the substrate, ES the hemin-peptide-
substrate ternary complex, EAS the corresponding active
species-substrate complex, k1 the active species forma-
tion constant, k	1 the kinetic constant for the transforma-
tion of ES into EAS, kP the kinetic constant for product
formation, kC and k	C the kinetic constants for decompo-
sition of peroxide by EA and EAS, respectively, and KB
and K	b the substrate affinity constants for E and EA,
respectively (Monzani et al., 2001).
Under the assumptions described for hemin-HSA cataly-
sis (Monzani et al., 2001) and operating under saturating
Scheme 1.
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concentration of phenolic substrate, the rate equation for the
above catalytic scheme can be reduced to:
r 
Kp/k	ck	1H2O2E0/
kp/k	C H2O2,
where [E0] is the initial concentration of hemin complex.
The kinetic parameters that can be obtained by studying the
dependence of the substrate oxidation rate on peroxide
concentration are the rate constant k	1, measuring the forma-
tion rate of the active species in the presence of substrate,
and the ratio kP/k	C, ruling the competition between peroxi-
dase and catalase activity and, therefore, the efficiency of
the complex in the peroxidase reaction. The values of these
parameters obtained from the kinetic experiments are col-
lected in Tables 2 and 3.
Relaxometric characteristics
A 1.0 mM solution of hemin-C was investigated from the
relaxometric viewpoint as a function of pH and temperature.
As expected for an S 1/2 system, the millimolar relaxivity
r1p at 20 MHz shows a value of 0.30 s
1 mM1, at 25°C and
pH 7.0, which is markedly smaller than that reported for
hemin-HSA (r1p  4.8 s
1 mM1) (Fasano et al., 2001).
This value is further reduced by increasing the temperature,
as expected for a low-spin complex lacking coordinated
water molecules. When the pH of the hemin-C solution is
increased, a marked change in the solvent water relaxivity is
observed (Fig. 2) and a r1p value of 2.28 s
1 mM1 is
reached at pH	 10. The relaxivity change is consistent with
a single equilibrium, with a pKa value of 8.77  0.07.
Measurements of 17O-NMR linewidth as a function of
temperature (data not shown) are consistent with the ab-
sence of a coordinated water molecule in the inner sphere of
Fe(III) in hemin-C at any pH value. This observation gives
further support to the view that a transition from a six-
coordinated His2Fe center to a five-coordinated ferric heme
is occurring at basic pH.
Replacement of ferric hemin by its Mn(III) analog allows us
to deal with systems endowed with higher relaxivity values.
Mn(III)-protoporphyrin complexes are reported to be often in
the high-spin state, i.e., with four unpaired electrons (Mashiko
and Dolphin, 1987). Therefore, a direct comparison with the
full-length Mn(III)-PPIX-HSA derivative can be performed.
The millimolar relaxivity of Mn(III)-PPIX-C is almost un-
changed at different pH values, except for small fluctuations
that could be attributed to conformational transitions in the
protein fragment and decrease exponentially with temperature
(Fig. 3). The complexMn(III)-PPIX-HSA (Fasano et al., 2001)
displays larger relaxivity values than Mn(III)-PPIX-C at any
pH. A possible explanation for both smaller relaxivity and
temperature dependence is that Mn(III), like Fe(III), is coordi-
nated by two His residues. To ascertain the lack of any coor-
dinated water molecule, 17O linewidths ofMn(III)-PPIX-C and
of diamagnetic fragment C solutions partially enriched in
H2
17O were measured as a function of temperature. The extent
of the paramagnetic contribution to the transverse relaxation of
the 17O nucleus is determined by the occurrence of a scalar
coupling through the Mn(III)-H2O coordination bond (Aime et
al., 1998, 1999). Because the two solutions show almost iden-
tical 17O linewidths, the occurrence of a paramagnetic contri-
bution arising from the exchange of a water molecule directly
coordinated toMn(III)-PPIX has to be discarded. Nevertheless,
FIGURE 2 Water proton millimolar relaxivity of a hemin-C solution
(1.0 mM ferric heme, 1.2 mM fragment C) in PBS at 25°C as a function of
pH. The relaxivity increase is consistent with a single equilibrium, and the
dotted line indicates a pK  8.77  0.07 for the change in the spin state
of the paramagnetic center.
TABLE 2 Kinetic constants k1 (M
1 s1) for the catalytic oxidation of phenols by the hemin complexes in the presence of
hydrogen peroxide (0.1 M phosphate buffer at 25°C)
Complex 1 2 3 L-4* D-4*
Hemin-A 19  3 26  2 20  3 76  15 80  20
Hemin-B 17  1 80  10 80  10 260  60 250  60
Hemin-C 15  3 38  3 36  4 95  10 100  10
Hemin-D 50  7 45  7 60  15 240  40 230  50
*Data were determined under nonsaturating conditions for limited solubility.
TABLE 3 Kinetic constants kp/kc (mM) for the catalytic
oxidation of phenols by the hemin complexes in the presence
of hydrogen peroxide (0.1 M phosphate buffer at 25°C)
Complex 1 2 3 L-4 D-4
Hemin-A 100  20 28  3 43  2 9  2 9  3
Hemin-B 53  3 16  3 10  2 3  1 4  1
Hemin-C 80  20 20  2 8  1 8  1 7  1
Hemin-D 55  9 21  4 3  1 2.0  0.4 2.0  0.4
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we observe a relaxivity value that is even smaller than that
observed for Mn(III)-PPIX-HSA at pH 10, i.e., when no di-
rectly coordinated water molecules are present. Again, the
different contribution of outer sphere water molecules close to
the paramagnetic center could be invoked to justify the ob-
served data.
ES/MS analysis of the hemin-C complex
The hemin-C complex, eluted from a PD10 column in 50
mM ammonium acetate, pH 7.0, at a concentration of 10
pmol/l, was directly analyzed by ion spray mass spectrom-
etry, producing the spectrum shown in Fig. 4. The most
abundant species (component A) showed a molecular mass
of 19,972.1  1.0 Da, corresponding to the isolated frag-
ment C with Met-298 in its homoserine lactone form. The
molecular mass of component B was measured as
20,589.2  1.2 Da, with a mass increase of 616 Da as
compared with fragment C, corresponding to the binding of
a single hemin molecule. Moreover, the mass spectrum
showed the occurrence of a very minor species (component
C) whose molecular mass indicated the binding of two
hemin molecules to fragment C. The results of this mass
spectral investigation indicate that fragment C essentially
binds hemin with a 1:1 stoichiometry. The presence of a
major species corresponding to the unbound form of frag-
ment C in the spectrum is very likely a result of the partial
dissociation of the complex in the gaseous phase during
mass spectral analysis. Finally, the occurrence of a minor
component with two hemin molecules linked to the protein
results from the conditions of excess hemin used in the
preparation of the sample. This compound might be inter-
preted either in terms of the existence of two different
hemin binding sites in fragment C or, more likely, by the
interaction of a hemin dimer within the same site of the
protein, in view of the high tendency of hemin to form
dimers in aqueous solution, as demonstrated by ES/MS
analysis of dilute hemin solutions (data not shown).
Limited proteolysis and mass spectrometry
The interaction of hemin with fragment C was investigated
by a strategy that combines limited proteolysis experiments
with mass spectrometric procedures (Zappacosta et al.,
1996; Scaloni et al., 1998; Orru` et al., 1999). The overall
strategy is based on the evidence that amino acid residues
located within exposed and flexible regions of the protein
can be recognized by proteases, leading to a good imprint-
ing of the protein conformation in solution. When these
experiments are performed on both the isolated protein and
a protein complex, one may draw useful insight into con-
formational changes and/or inaccessibility of protein re-
gions due to binding of the ligand.
Limited proteolysis experiments were performed on frag-
ment C and hemin-C by using trypsin, protease V8, subtili-
sin, and chymotrypsin as proteolytic probes. The protein
FIGURE 3 Effect of the pH value on the relaxivity for Mn(III)heme-C at
25°C. Fragment C concentration was 1.2 mM in PBS, and Mn(III)-
protoporphyrin concentration was 1.0 mM.
FIGURE 4 Transformed electrospray mass spectrum
of the hemin-C complex. The individual species are
indicated by capital letters. The molecular masses of the
various components are reported.
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and the complex were incubated with each protease under
strictly controlled conditions to ensure the maintenance of
native conformation. The extent of enzymatic hydrolysis
was monitored by reverse-phase HPLC; the fragments re-
leased from the proteins were identified by ES/MS leading
to the assignment of the cleavage sites.
Under the controlled conditions used for trypsin hydrolysis
of fragment C (E/S 1/1000, w/w) only a few specific fragments
were released; ES/MS analysis of individual fractions identi-
fied these fragments as peptides 124–190, 124–195, and 124–
197. The presence of the complementary peptide pairs 191–
298, 196–298, and 198–298, clearly indicates that these
fragments originated from single proteolytic events that oc-
curred on the native fragment at the level of Lys-190, Lys-195,
and Arg-197. Similar results were obtained with protease V8
as indicated in Table 4. Cleavages at Glu-184 and Glu-188
generated two complementary peptide pairs of fragments
whereas the proteolytic events occurring at Glu-208, Glu-227,
and Glu-230 caused the excision of internal regions of the
protein, because of the presence of the disulfide bridge be-
tween Cys-200 and Cys-246.
Additional limited proteolysis experiments were then car-
ried out by incubating fragment C with broader specificity
proteases such as chymotrypsin and subtilisin (Table 4). As
an example, the mass spectral analysis of the chymotryptic
digestion of the protein revealed the occurrence of primary
cleavage sites at Phe-211, Trp-214, and Leu-219, as inferred
from the identification of the species (124–214)-(220–298)
and (124–211)-(215–298), characterized by the presence of
a disulfide bridge linking the two peptides.
The experimental approach described above was then
used to investigate the surface topology of hemin-C. The
complex showed a generally lower accessibility to proteases
than the ligand-free HSA fragment, as demonstrated by the
higher E/S ratio needed to observe proteolytic cleavages,
thus suggesting that the interaction with hemin increased the
compactness of fragment C causing a general decrease in
the rate of hydrolysis. The preferential cleavage sites ob-
served on the hemin-C complex are listed in Table 4.
Compared with fragment C in the apo form, the complex
exhibits a similar pattern of cleavage sites within the -he-
lical region spanning residues from 174 to 205 (h10(I)–
h1(II) (Carter and Ho, 1994)), except for Glu-204, which is
now inaccessible to proteases, whereas complete protection
of the cleavage sites occurs in the region of h2(II), contain-
ing Glu-208, Phe-211, and Trp-214.
DISCUSSION
Hemin binds tightly to HSA in a cleft that leaves little space
for the addition to the iron center of even small high-affinity
ligands (Monzani et al., 2001). The spectral features of the
hemin-HSA complex are consistent with an equilibrium
between a major high-spin and a minor low-spin species.
Reactivity studies using hydrogen peroxide and exogenous
substrates confirmed the limited access to the heme
(Monzani et al., 2001). The spectroscopic and binding stud-
ies carried out on the hemin-D complex, where the protein
moiety corresponds to HSA depleted of the C-terminal
fragment A, show that this large D fragment, but not the
smaller C fragment (Hrkal et al., 1978), contains the entire
HSA domain I proposed to act as the hemin binding site
(Dockal et al., 1999). Recent studies indicate a contribution
from its C-terminal domain IIA, possibly with a histidine
and/or a tyrosine acting as iron axial ligands in the major
high-spin species (Fasano et al., 2001). The electronic spec-
tral properties and especially the induced CD pattern in the
Soret region, which reflects the interactions between the
transition moments of the porphyrin and those located in the
chromophores of the protein residues in the heme environ-
ment, are almost identical for hemin-D (Fig. 1) and hemin-
HSA (Casella et al., 1993). The minor differences observed
for the two complexes can be ascribed to an increased
flexibility in the peptide chain surrounding the heme in
fragment D, allowing a somewhat easier approach of the
endogenous ligand to the iron center.
This view is supported by the behavior of the hemin-C
complex. This protein fragment is smaller than D, as it is
further depleted of a consistent portion of the N-terminal
polypeptide chain, and contains only part of the hemin
binding site located within HSA domain I. Hemin-C ap-
pears to be totally low spin, with two imidazole groups
acting as protein axial ligands, both of which are probably
different from those present in hemin-HSA and hemin-D.
The existence of some local mobility in the peptide chain
carrying the sixth ligand is shown by the reversible change
to a five-coordinated structure observed in basic medium.
The lack of formation of a low-spin, hydroxymet species in
these conditions, as it is observed, for instance, for the
oxygen carrier proteins (Antonini and Brunori, 1971), is
highly unusual in heme-protein coordination chemistry and
indicates that also for fragment C the protein pocket hosting
the heme must be tight and basically inaccessible to small
TABLE 4 Map of the preferential cleavage sites observed in the isolated fragment C and in the hemin-C complex
Protease Fragment C Hemin-C
Trypsin Lys-190, Lys-195, Arg-197 Lys-190, Lys-195, Arg-197
Endoprotease V8 Glu-184, Glu-188, Glu-208,* Glu-227,* Glu-230* Glu-184, Glu-188, Glu-227,* Glu-230*
Chymotrypsin Phe-211,* Trp-214,* Leu-219* Phe-206,* Leu-219*
Subtilisin Ser-192, Ala-194, Gln-204,* Ser-232* Ser-192, Ala-194
*Cleavage sites producing excision of internal peptides from the protein owing to the presence of disulfide bridges.
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polar molecules. The opposite CD behavior within the Soret
band between the high-spin hemin C derivative in basic
medium and the corresponding high-spin components of
hemin-D and hemin-HSA complexes is a signature of the
different nature of the polypeptide chains around the heme
group. A similar trend can be noted also between the in-
duced CD patterns of the low-spin components. The Soret
CD band of hemin-C in neutral medium (Fig. 1) is in fact
opposite to those of the corresponding low-spin forms of
hemin-D and hemin-HSA at the equilibrium in solution.
In addition to the high-affinity binding site, HSA has
other heme-binding centers with lower affinity, which can
be located in different portions of the polypeptide chain. As
shown in the present study, a relatively strong hemin-bind-
ing site is present in fragment A and another, less strong, in
fragment B. The characteristics of iron coordination in the
two cases are different, six-coordinated low spin in hemin-A
and five-coordinated high spin in hemin-B, but with histi-
dine residues involved as axial ligands in both cases. How-
ever, the lack of any significant CD features for these
complexes seem to indicate the existence of more than a
single binding site with similar affinity for hemin in these
HSA fragments. The reactivity studies performed with hy-
drogen peroxide and several exogenous substrates confirm
that even for hemin-A and hemin-B, as well as for hemin-C
and hemin-D, the approach to the heme is basically re-
stricted to molecules of relatively small size such as the
phenols investigated here, independently of the absence or
presence of charges on their substituents.
Some general comments on the kinetic data are worth
mentioning in the present context, because they bear on the
structural features of the hemin complexes. The kinetic
constant k	1 reflects the differences in the binding site envi-
ronment of the heme and the activation of acid-base catal-
ysis by the polar substrates. Thus, with p-cresol, which lacks
polar groups in the substituent, k	1 is very small for all
hemin-peptide complexes carrying a low-spin iron center,
whereas somewhat larger values are observed for those
complexes in which an equilibrium between high-spin and
low-spin species exist, i.e., hemin-D (Table 2) and hemin-
HSA (Monzani et al., 2001). For substrates 2–4, the k	1
values are generally larger than for 1, indicative of a con-
tribution of acid-base catalysis in the cleavage of the per-
oxide O-O bond by the polar substituents of the phenol. The
kP/k	C values are basically controlled by the redox potential
of the phenols (Monzani et al., 1997), and in fact the highest
activities are observed with the most easily oxidizable sub-
strate 1 (Table 3). In general, it is clear that only the k	1 and
kP/k	C values exhibited by hemin-D with the various sub-
strates are close to those found for hemin-HSA (Monzani et
al., 2001), reflecting a similar arrangement of the substrates
near the heme in the catalytic process. For the hemin com-
plexes with the other HSA fragments the differences in the
heme environment dictate that also the mode of interaction
of the substrates near the heme will be different.
The structural effects determined by cleavage of the N-
terminal fragment B of HSA are of some interest because
fragment C contains the binding region, termed Sudlow’s site
I (Sudlow et al., 1975), which is located in domain IIA span-
ning from residue 199 through 292 of HSA (He and Carter,
1992). Several important ligands are believed to bind in this
region; bilirubin, warfarin, and salicylates can be accommo-
dated, and more than one at a time, without significant inter-
ference. We therefore decided to investigate in more detail the
properties of this hemin-C complex, where the heme group can
be exploited as a reporter probe of the protein environment.
The pH-dependent spin state change undergone by hemin-C
is expected to dramatically affect the relaxation of solvent
water protons in the solution (Fasano et al., 2001; Baroni et al.,
2001). The low-spin form present in neutral solution is actually
characterized by a very low effect on the relaxation rate of
water protons. The millimolar relaxivity r1p at 20 MHz (0.30
s1 mM1) is significantly smaller than that reported for
hemin-HSA (4.8 s1 mM1) (Fasano et al., 2001), even
though a change in the number of mobile hydrogens may
contribute to a potential second sphere effect.
With the transition of hemin-C to the high-spin form at basic
pH, a marked increase in the solvent water relaxivity is ob-
served (Fig. 2). Actually, the relaxivity value in these condi-
tions (2.28 s1 mM1) is larger than those reported for most
ferric oxygen carriers. In the case of sperm whale (Physeter
catodon) myoglobin, horse (Equus caballus) myoglobin, log-
gerhead sea turtle (Caretta caretta) myoglobin, and human
hemoglobin (Aime et al., 1993, 1996), the paramagnetic con-
tribution to the water relaxation rate is in the range of 0.8–1.2
mM1 s1 at 20MHz. Although the increase of relaxivity with
pH is clearly due to a spin-state change, the effect of the S 
5/2 paramagnetic center needs to be amplified by some of the
residual water molecules that are still buried in the protein core
after the cleavage. Therefore, the observed value, which is
intermediate between those for ferric, high-spin oxygen carri-
ers and ferric, high-spin hemin-HSA, reflects both a lower
reorientational correlation time for the HSA fragment and a
smaller number of water molecules contributing to the second
sphere effect (Halle et al., 1999).
Replacement of hemin Fe(III) with Mn(III) has a strong
influence on the spectral, binding, and relaxometric prop-
erties of the protein complexes. Mn(III)-PPIX binds less
strongly than hemin to both HSA and fragment D but more
strongly than hemin to fragment C. This difference can be
attributed to the easier formation of the metal complex with
bis-histidine ligation in fragment C. The larger paramagnet-
ism of Mn(III)-PPIX-C produces higher relaxivity effects of
water protons compared with its Fe(III) analog, and in
addition, for the Mn(III) derivative both the spectral features
and relaxivity effects are basically unchanged with pH,
indicating that the polypeptide chain carrying the sixth axial
ligand is more conformationally rigid than in hemin-C.
Fig. 5 shows a ribbon diagram of HSA fragment C as
obtained from the x-ray coordinates of HSA (Protein Data
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Bank code 1bm0) (Sugio et al., 1999). The main feature is
the long interdomain helix (namely, h10(I)-h1(II) (Peters,
1996), residues 177–205), which is docked to helices h8(I)
and h9(I) to form a three-helix bundle capped by helix h7(I).
This motif is orientated perpendicular to the assembly
formed by helices h2(II) to h6(II). Obviously, the structural
model obtained by simply cutting the atomic coordinates of
the fragment from the atomic coordinates of the whole
protein is far from being representative of the actual solu-
tion structure of fragment C. Moreover, HSA fragments are
expected to possess an intrinsic conformational flexibility,
because many contacts have been removed.
The results of the spectroscopic, reactivity, and relaxo-
metric studies can thus be combined with proteolysis/MS
experiments to forward a suggestion for a potential heme-
binding site in the fragment C model. Limited proteolysis
data performed on the ligand-free fragment C indicate that
preferential proteolytic sites are gathered within helices
h10(I)-h1II) and h2(II). A quite similar distribution of cleav-
age sites was observed within the -helical h10(I)-h1(II)
region for hemin-C, with only Gln-204 being inaccessible in
the complex. This finding would suggest that h10(I)-h1(II)
is actually solvent exposed in hemin-C. On the contrary,
differences were detected in the region of helix h2(II),
where Glu-208, Phe-211, and Trp-214 were completely
protected from proteases in the complex (Table 4). These
data suggest that the region encompassing residues Glu-208
to Trp-214 is involved in the interaction with hemin and,
therefore, is protected from the activity of proteases. This
helix constitutes a definitely hydrophobic stretch (in black
in Fig. 5) and could be indicated as the docking site for
hemin to fragment C. If we compare the binding site char-
acteristics of the heme in HSA and fragment D with those in
fragment C we note that cyanogen bromide cleavage of the
N-terminal HSA portion (B) forces hemin to bind in a
protein cleft that is different but just adjacent to that used by
HSA and fragment D. This cleft is lined by residues Glu-
208, Phe-211, and Trp-214 and constitutes the subpocket in
which the benzyl moiety of warfarin is bound, predomi-
nantly through hydrophobic contacts (Petitpas et al., 2001).
It should be emphasized that the imidazole ring of His-242
(black sticks in Fig. 5) is in close proximity to the hydro-
phobic pocket defined by these residues and might then
constitute the fifth axial ligand to the iron atom. Tyr-148
seems to be accessible to Fe(III), but the different orienta-
tion of the porphyrin caused by the new stabilizing contacts
makes coordination of this residue unsuitable. A different
ligand, with stronger ligand field, occupies the sixth iron
coordination position in hemin-C, very likely a second
histidine residue. This residue could be His-288 (see Fig. 5),
which belongs to a structural element lacking stabilizing
contacts with the part of the polypeptide chain that has been
removed by the cyanogen bromide cleavage; thus it could
rearrange to form the low-spin bis-histidine complex
present in this complex. A large flexibility of this region is
also suggested by the conformational transition undergone
by this complex from neutral to basic pH.
An analysis of the charge distribution indicates that these
structural components have opposite charge, with residues
belonging to domain I endowed with a positive charge and
helices h3(II) to h6(II) with a large negative potential. His-242
is located within the crevice formed by the structural elements
with opposite charge distribution, i.e., in a region where the
electrostatic potential is lower. Basic residues such as Lys-195
and Arg-218 (see Fig. 5) should contribute to the hemin dock-
ing by providing salt bridges to hemin propionates.
In conclusion, the picture emerging from the present
comparative studies on HSA fragments indicates that hemin
binds to fragment C in the region usually indicated as
Sudlow’s site I, which is located in proximity to the site
where hemin binds to both fragment D and full-length HSA.
This is in keeping with the observation that the binding
clefts for hemin and warfarin in HSA are functionally and
spectroscopically linked (Baroni et al., 2001).
Note that after completion of this work, a structural
description of the heme binding site in HSA has been
reported at the atomic level (Wardell et al., 2002).
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